Clinical Trial to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Adults With CF - PHASE2 - RECRUITING
ongoing trials trial from www.clinicaltrials.gov
Details- 2024
- Kors van der Ent
Bionic Pancreas in CFRD - PHASE3 - NOT_YET_RECRUITING
ongoing trials trial from www.clinicaltrials.gov
Details- 2024
- Jaeb Center for Health Research
Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People With Cystic Fibrosis - Phase 1|Phase 2 - Recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2023
- Cystetic Medicines, Inc.|DevPro Biopharma
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis - - RECRUITING
ongoing trials trial from www.clinicaltrials.gov
Details- 2024
Maralixibat in Patients With Cystic Fibrosis and Constipation, A Within-Subjects Pilot Study - - NOT_YET_RECRUITING
ongoing trials trial from www.clinicaltrials.gov
Details- 2024
Tolerability and Safety of Inhaled Colistimethate Sodium (CMS) Administered Once Daily Compared to Twice Daily Dosing in Adult and Adolescent Subjects with Cystic Fibrosis and Chronic Pseudomonas Aeruginosa Lung Infection (COPILOT) - Not yet recruiting
ongoing trials trial from other registries
Details- 2024
A randomised, double-blind, placebo controlled, two-part study to evaluate the efficacy, safety, tolerability and pharmacokinetics of a repeat dose of inhaled ETD001 in people with cystic fibrosis - Ongoing
ongoing trials trial from other registries
Details- 2024
A Phase 3, Open-label Study Evaluating the Long term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects 12 Months of Age and Older
ongoing trials trial from other registries
Details- 2024
A Phase 3 Study Evaluating the Pharmacokinetics, Safety, and Tolerability of VX 121/Tezacaftor/Deutivacaftor Triple Combination Therapy in Cystic Fibrosis Subjects 1 Through 11 Years of Age (VX21-121-105)
ongoing trials trial from other registries
Details- 2024
A Phase 3 Open-label Study Evaluating the Long term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor Triple Combination Therapy in Cystic Fibrosis Subjects 2 Years and Older
ongoing trials trial from other registries
Details- 2024